Kingdom Financial Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Kingdom Financial Group's NVO Position: Q2 2026 in Review
Kingdom Financial Group reduced its Novo Nordisk (NVO) stake by 4.6% in Q2 2026, selling an estimated $2.88K and leaving 1,374 shares worth $65.9K. The position accounts for 0.02% of the portfolio, ranked #232.
Kingdom Financial Group first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Kingdom Financial Group held 1,374 shares of Novo Nordisk worth $65.9K as of Q2 2026.
- Kingdom Financial Group sold 67 Novo Nordisk shares in Q2 2026, an estimated $2.88K.
- Novo Nordisk made up 0.02% of Kingdom Financial Group's portfolio in Q2 2026, its #232 holding.
- Kingdom Financial Group first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Kingdom Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.